Most patients with lymphoma have a reduced serum albumin concentration, often despite adequate nutrition and without evident liver disease or urinary protein loss (1-6). The etiology of this hypoalbuminemia is not clear. Possible causes include dilutional hypoalbuminemia, decreased albumin synthesis, increased albumin catabolism within the body, or excessive loss of albumin from the body through the kidneys or the gastrointestinal tract.
Most patients with lymphoma have a reduced serum albumin concentration, often despite adequate nutrition and without evident liver disease or urinary protein loss (1) (2) (3) (4) (5) (6) . The etiology of this hypoalbuminemia is not clear. Possible causes include dilutional hypoalbuminemia, decreased albumin synthesis, increased albumin catabolism within the body, or excessive loss of albumin from the body through the kidneys or the gastrointestinal tract.
Steinfeld (7) studied the metabolism of I131-labeled albumin in twelve patients with neoplastic diseases, including one with lymphoma. The survival of albumin was normal or prolonged in these patients, whereas the albumin synthetic rate was reduced. This decreased synthetic rate was felt to be the primary defect leading to the hypoalbuminemia. Jarnum and Schwartz (8) , however, demonstrated gastrointestinal protein loss in seven patients with hypoalbuminemia and gastric carcinoma by using I131-labeled polyvinylpyrrolidone. They concluded that this loss of albumin was the cause of the hypoproteinemia seen in their patients and that deficient protein synthesis was not a significant factor. Gastrointestinal protein loss has also been reported in two patients with hypoproteinemia and lymphoma (9, 10) .
In the present study, albumin metabolism was studied with 1131-albumin in a series of patients with lymphoma to measure the plasma and total body albumin pools, as well as the rate of albumin degradation and synthesis. I131-polyvinylpyrrolidone (PVP) was used to determine if excessive gastrointestinal protein loss was present in these patients. opsy who were capable of making the required urine and stool collections. An I"1'-albumin turnover study was performed on these patients during a period of active disease. They were hospitalized throughout the 4-to 6-week study, and their weights, temperatures, and caloric intakes were determined daily. Specific antitumor therapy was withheld during this period.' Pertinent clinical data are recorded in Table I . The twenty cases included twelve patients with Hodgkin's disease, three with giant follicular lymphoma, three with lymphosarcoma, one with reticulum cell sarcoma, and one with chronic lymphocytic leukemia and lymphosarcoma. The fifteen men and five women studied ranged in age from 11 to 71 years. Except for Patients 2 and 14, each patient had an adequate caloric intake and a stable body weight during the study. Intermittent fever was present in six cases. Three patients had large bilateral pleural effusions and ascites. None had proteinuria or elevation of the blood urea nitrogen. Liver function tests revealed minor abnormalities in seven patients; five of these had increased levels of serum alkaline phosphatase. In Patient 17 hypercalcemia and bone lesions were prominent. Elevated levels of serum glutamic oxaloacetic transaminase were noted in Patients 4 and 14; Patient 14 had abdominal surgery 10 days before this determination, which may account for this abnormality. There was no clear explanation for these elevated levels in Patient 4.
The patients had a variety of gastrointestinal symptoms, including anorexia in seven patients, severe diarrhea in three, and abdominal pain in two. Patient 18 had steatorrhea with a fecal fat excretion of 18 g per day on a 100-g intake. X-ray examination of his upper gastrointestinal tract showed considerable coarsening of the mucosal folds of the jejunum and ileum. Per oral biopsy specimens revealed dilated mucosal lymphatic channels. Patient 14 had a grossly distorted rigid stomach with irregular filling defects noted on X-ray studies. At laparotomy the entire stomach of this patient was found to be involved in an inoperable lymphomatous mass. Patient 20 had severe diarrhea and abdominal pain. At post-mortem examination there were numerous ulcerations of the stomach at the site of tumor nodules that extended through the wall of the lesser curvature.
The ten subjects used as controls for the I"1'-albumin studies included six normal volunteers and four patients with idiopathic epilepsy. (11) . Serum samples obtained weekly were analyzed by paper electrophoresis by a modification of a method of Henry, Goluk, and Sobel (12) . There were no significant changes in the serum albumin concentrations in any of the patients throughout the period of study.
Analysis of the data. The data were analyzed according to the methods of Berson, Yalow, Schreiber, and Post (13) and Steinfeld (14) . In summary: plasma volume = total activity administered/activity per milliliters of plasma at zero time (extrapolated from 15-and 30-minute values), total circulating albumin = plasma volume X albumin concentration, and total body radioactivity = total activity administered minus the cumulative excretion of radioactivity in the urine and stools. The half-time survival (ti) of I3"-albumin was determined from the slope of a semilogarithmic plot of both the total body radioactivity and serum radioactivity against time ( Figure 1 ). The fractional degradation rate = 0.693/ I1"'-albumin survival tf in days. After completion of the distribution phase of P`1-albumin, the percentage of the body albumin that is intravascular may be estimated from: plasma volume X plasma radioactivity per milliliter X 100/total radioactivity retained in the body. The total body albumin pool = total circulating albumin X 100/ per cent of body albumin that is intravascular. The albumin turnover = total body albumin pool X fractional degradation rate determined from the whole body radioactivity curves. In the steady state, the grams of albumin degraded or lost per day, the albumin turnover, is equal to the albumin synthetic rate.
I15-polyvinylpyrrolidone. I"~-albumin entering the gastrointestinal tract is rapidly digested into the constituent amino acids and radioiodine and then absorbed. P`- 
RESULTS
The results of the serum electrophoretic analyses are shown in Table II . The most striking feature is a reduction in the serum albumin concentration. Eighteen of the twenty patients had a serum albumin concentration below 3.5 g per 100 ml, the lower limit of the normal range. In 4 Prepared by the radiopharmaceutical service of the Pharmacy Department, National Institutes of Health, Bethesda, M1d. (16) .
four patients the total serum globulin levels were increased. Nine patients had an a1-globulin level above 0.4 g per 100 ml, whereas six, five, and five patients, respectively, had serum a2-, fl-, and yglobulin concentrations greater than normal; these were below normal in two of the patients. This was most marked in Patient 18, who had a significant reduction of all serum protein concentrations, with a marked reduction in the y-globulin concentration to 0.16 g per 100 ml.
The results of the 131-albumin degradation studies are shown in Table III . The total circulating albumin was low in all sixteen patients who had an albumin concentration below 3.5 g per 100 ml at the time of the protein turnover studies. This indicates that the reduced serum albumin concentrations were not primarily due to plasma volume expansion. The total body albumin pool was below the normal range in thirteen of the patients who had no effusions. The subjects with effusions, however, had a marked decrease in the percentage of body albumin that was intravascular and had a normal or increased total body albumin pool. Thus, an abnormal distribution of albumin was a major factor in the marked reduction in serum albumin concentration seen in these patients with ascites and pleural effusions.
The fractional degradation rate of I'81-albumin was normal in fifteen of the patients without effusions and slightly increased in two (Patients 9 and 16). The percentage of the body albumin pool degraded per day was significantly reduced in the three patients with protein-rich effusions. Fecal excretion of the radioiodine was negligible in all patients with a maximal daily fecal J131_ excretion of 0.04 per cent of the retained dose. The albumin synthetic rate (albumin turnover) was reduced below that seen in the controls in fifteen of the patients, and appears to be the major factor in the hypoalbuminemia associated with lymphoma. The percentage of the administered PVP excreted in the 4-day stool collection was normal for each of the patients with lymphoma studied, with a mean of 0.6 and a range of 0.4 to 0.9 per cent, compared to the mean and range in controls of 0.7 and 0 to 1.5 per cent, respectively. Patients with known gastrointestinal protein loss had a 
DISCUSSION
Hypoalbuminemia has been noted in most of the patients with lymphoma (1-6), progressing in severity with increasing extent and duration of the neoplastic disorder (3, 6) . The demonstration of a reduced total circulating albumin in most of our patients with low serum albumin concentrations accords with Steinfeld's (7) findings in twelve patients with various neoplastic disorders. These results suggest that dilution due to plasma volume expansion was not a major factor in the reduced serum albumin concentrations observed.
Another factor of importance is the distribution of albumin between the intravascular and extravascular compartments. In the three patients studied with large protein-rich effusions, there was a marked decrease in the percentage of albumin within the intravascular space, with a consequent reduction in the serum albumin concentration despite normal or elevated total body albumin pools. A similar decrease in the percentage of intravascular body albumin has been noted in patients with cirrhosis and ascites (18) and with idiopathic chylous effusions (19) . Freeman and Mathews (20) have indicated that an estimate of the total body pool by the methods of Berson and co-workers (13) used for the present study may be unreliable if the protein breakdown is confined to the intravascular compartment, since the specific activity of the protein would not be uniform throughout the body. The magnitude of the error is a function of the rates of protein turnover and the rate of exchange between the extravascular and intravascular compartments. In patients with nephrosis this error is exceedingly large (21) . When the protein survival tj is long, however, as in the present study, the error is not significant. In the three patients with effusions, the specific activity of the albumin of the pleural fluid was almost identical with that of the serum after 9 days (Table IV) , indicating that the equilibration of the I131-albumin between the body compartments required for calculation of the total body albumin pool size had occurred.
The fraction of the body pool of I'31-albumin degraded per day was within the normal range in fifteen of the patients without effusions and was slightly increased in two cases (Patients 9 and 16). A moderate increase in the fractional rate of albumin catabolism has been noted in animals and man in association with steroid administration (22) , fever (22) , and in the hypermetabolic states (23, 24) . Patient 9 had a range of basal metabolic rates from 51.7 kcal per m2 per hour (+ 34 per cent) to 56.3 kcal per m2 per hour (+ 46 per cent) in three determinations, but had a protein bound iodine of 6.1 ,ug per 100 ml, whereas Patient 16 was receiving 200 mg of prednisolone during the study, possibly explaining the increased rate of albumin catabolism seen in these subjects.
In the three patients with large protein-rich effusions, there was a significant reduction in the fraction of the body pool of I13-albumin degraded per day. Campbell, Cuthbertson, Mathews, and
McFarlane (25) , Lewallen, Berman, and Rall (26) , Veall and Vetter (27) , and Berson and Yalow (18) report that albumin degradation occurs only in the intravascular compartment or in a small, rapidly exchanging, extravascular com- 2. Serum albumin concentration, total circulating albumin, and total body albumin pools were reduced in 13 of the 17 patients without effusions who were studied with T131-albumin.
3. The 3 patients with large protein-rich effusions had low serum albumin concentrations and low total circulating albumin values but normal or increased total body albumin pools, indicating that an abnormal distribution of albumin between the intravascular and extravascular compartments was the major factor in the reduced serum albumin concentrations.
4. The fraction of the body albumin degraded per day was normal in 15 and slightly increased in 2 of the patients without effusions.
5. The fraction of the body albumin pool degraded per day was reduced in each of the 3 patients with effusions. 6 . None of the patients had evidence of excessive gastrointestinal protein loss.
7. Each patient with a low serum albumin concentration had reduced albumin synthesis. This defect in albumin synthesis appears to be the major factor in the hypoalbuminemia in this group of patients with lymphoma.
